Sepsis education for ICU patients
Part of Infections clinical trials.
This study tests whether a simple written guide about sepsis can help you understand your condition and recovery better while you are in the ICU. If you qualify, you will receive the educational material and may be asked a few questions about your experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sepsis and are being treated in the ICU.
- You are at least 18 years old.
- You can read basic English.
- You have not been readmitted to the ICU during this hospital stay.
- Your hospital stay has not already lasted longer than 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This study tests a new, timely approach to managing sepsis (a severe infection that can harm the body). It aims to improve care in the Emergency Department and Intensive Care Unit, which could help patients recover faster.
This study follows up with patients who had sepsis in the ICU to understand their long-term health outcomes. It may help improve care for future patients.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.